A novel non-invasive method for using carbon-13 magnetization transfer effects to determine and evaluate in vivo aspartate transaminase (AST) activity and levels in an organ, as a biomarker of disease and certain neurological disorders. More
A number of specific PPLs, a group of prenylflavanone compounds, some novel, were isolated, identified and tested at as low as 0.04 μg/mL to be able to increase survival of neural stem cells, to promote neuronal growth with lengthening of neurite More
These radioactive compounds have the very unique and unprecedented ability to bind very specifically and irreversibly to butyrylcholinesterase (BChE). More
KD501 is a partially purified extract from Scrophulariae Radix, which shows an efficacy for the treatment of strokes and degenerated neuronal disease in vivo. Elcom filed an IND application with the KFDA (The Korea Food & Drug Administration) in May More
Reperfusions can lead to sever damage in patients with heat attacks and strokes, the SOD-nanoparticles would be highly beneficial for use in hospitals for treating these patients. More
CSIC has patented a series of derivatives with neuroprotective activity when subjected to biological evaluation, and its use in a potential treatment of diseases in which oxidative processes play a crucial role, such as the Alzheimer’s disease. More
CSIC has patented a series of new glutamic acid derivatives that show several pharmacological activities in a single small molecule, particularly in a potential treatment of the Alzheimer’s disease. More
All rights reserved. Terms and Conditions | Contact us
